Your browser doesn't support javascript.
loading
The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of ß-Thalassemia.
Nyffenegger, Naja; Flace, Anna; Doucerain, Cédric; Dürrenberger, Franz; Manolova, Vania.
Affiliation
  • Nyffenegger N; Vifor (International) Ltd., Rechenstrasse 37, 9014 St. Gallen, Switzerland.
  • Flace A; Vifor (International) Ltd., Rechenstrasse 37, 9014 St. Gallen, Switzerland.
  • Doucerain C; Vifor (International) Ltd., Rechenstrasse 37, 9014 St. Gallen, Switzerland.
  • Dürrenberger F; Vifor (International) Ltd., Rechenstrasse 37, 9014 St. Gallen, Switzerland.
  • Manolova V; Vifor (International) Ltd., Rechenstrasse 37, 9014 St. Gallen, Switzerland.
Int J Mol Sci ; 22(2)2021 Jan 16.
Article in En | MEDLINE | ID: mdl-33467196
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Oxazoles / Pyridines / Benzimidazoles / Beta-Thalassemia / Erythropoiesis Language: En Journal: Int J Mol Sci Year: 2021 Type: Article Affiliation country: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Oxazoles / Pyridines / Benzimidazoles / Beta-Thalassemia / Erythropoiesis Language: En Journal: Int J Mol Sci Year: 2021 Type: Article Affiliation country: Switzerland